A broad-host-range inhalable phage cocktail for treatment of multidrug-resistant Pseudomonas aeruginosa pulmonary infections
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1912918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Zixun Lin und 16 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Centre for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern Uni…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, Phage Therapy, Drug Resistance, Multiple, Bacterial. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The growing threat of multidrug-resistant (MDR) Pseudomonas aeruginosa ( P. aeruginosa) has created an urgent need for novel therapeutic strategies to combat refractory lung infections. The limited efficacy of traditional antibiotics against this pathogen highlights the necessity of developing alternative treatments. Our study aims to develop a broad-spectrum bacteriophage cocktail suitable for nebulization and to evaluate its antibacterial efficacy and safety in respiratory infections caused by MDR P. aeruginosa .
Methods
We constructed a seven-phage cocktail by selecting phages with complementary host ranges, strong lytic activity, and different receptor targets. The antimicrobial and anti-biofilm activity of the cocktail was assessed in vitro against clinical MDR P. aeruginosa isolates. The therapeutic efficacy and safety were further investigated in a murine pneumonia model following nebulized administration.
Results
The phage cocktail demonstrated lytic activity against nearly 90% of 152 clinical P. aeruginosa i solates, indicating broad coverage. Compared to single phages or antibiotics, the cocktail showed superior activity in both inhibiting and disrupting biofilms. In the murine pneumonia model, nebulized phage therapy improved survival, reduced bacterial burdens in lung and liver, and alleviated infection-related histopathological damage. Safety assessment revealed no obvious hematological, biochemical or histopathological abnormalities in both acute and long-term administration.
Conclusion
High-dose nebulized administration of this phage cocktail reduced bacterial burden and showed favorable tolerability in a murine model of MDR P. aeruginosa pneumonia. These findings provide preclinical evidence supporting further evaluation of inhaled phage cocktails as a potential therapeutic strategy for refractory respiratory infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Centre for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Southern University of Science and…
- School of Medicine, Southern University of Science and Technology, Shenzhen, China.
- PhageNovoTech Co., Ltd., Shenzhen, China.
- College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zitieren
APA
Lin, Z., Wan, X., Duan, X., Liang, S., Wang, X., Qu, J., Zhou, C., Ming, M., Zeng, Y., Han, S., Ling, Y., Gan, W., Wang, K., Yang, L., Zhou, X., Lu, H., & Shen, J. (2026). A broad-host-range inhalable phage cocktail for treatment of multidrug-resistant Pseudomonas aeruginosa pulmonary infections. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1912918
Vancouver
Lin Z, Wan X, Duan X, Liang S, Wang X, Qu J, et al. A broad-host-range inhalable phage cocktail for treatment of multidrug-resistant Pseudomonas aeruginosa pulmonary infections. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1912918
BibTeX
@article{Lin2026,
author = {Lin, Zixun and Wan, Xiaofu and Duan, Xiangke and Liang, Shuang and Wang, Xiaoqian and Qu, Jiuxin and Zhou, Chuandong and Ming, Min and Zeng, Yukun and Han, Shuhong and Ling, Yijia and Gan, Wenheng and Wang, Ke and Yang, Liang and Zhou, Xin and Lu, Hongzhou and Shen, Jiayin},
title = {A broad-host-range inhalable phage cocktail for treatment of multidrug-resistant Pseudomonas aeruginosa pulmonary infections},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1912918}
}
EUVIMED